Redirecting <scp>TRIM21</scp> with <scp>TRIMTACs</scp> for the targeted degradation of multimeric proteins

PROTACs (PROteolysis-Targeting Chimeras) are heterobifunctional small molecules that induce proximity between E3 ubiquitin ligases and target proteins to drive target protein ubiquitination and proteasomal degradation. TRIM21 is an intracellular Immunoglobulin G (IgG) receptor and E3 ubiquitin ligase that functions to degrade cytoplasmic antibody-coated viral particles. Genetic approaches have redirected TRIM21 towards a wide range of cellular proteins, and mechanistic studies have demonstrated TRIM21's preference for degrading multimeric substrates such as protein aggregates. Recently, the first small molecules targeting TRIM21 have been reported, including some that have been elaborated into PROTACs (TRIMTACs) that degrade multimeric proteins. In this State-of-the-Art review, we describe the unique biology of TRIM21, detail recently reported TRIMTACs, and suggest future opportunities for TRIMTACs to impact targeted protein degradation.

Authors

Institutions

Publication Details

Journal
FEBS Journal
Published
2026-04-21
DOI
https://doi.org/10.1111/febs.70548
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteins

Drew J. Adams, Marc A Scemama de Gialluly
FEBS Journal
Protein Degradation and Inhibitors
article

Redirecting TRIM21 with TRIMTACs for the targeted degradation of multimeric proteins

Drew J. Adams, Marc A Scemama de Gialluly
article en

Abstract

PROTACs (PROteolysis-Targeting Chimeras) are heterobifunctional small molecules that induce proximity between E3 ubiquitin ligases and target proteins to drive target protein ubiquitination and proteasomal degradation. TRIM21 is an intracellular Immunoglobulin G (IgG) receptor and E3 ubiquitin ligase that functions to degrade cytoplasmic antibody-coated viral particles. Genetic approaches have redirected TRIM21 towards a wide range of cellular proteins, and mechanistic studies have demonstrated TRIM21's preference for degrading multimeric substrates such as protein aggregates. Recently, the first small molecules targeting TRIM21 have been reported, including some that have been elaborated into PROTACs (TRIMTACs) that degrade multimeric proteins. In this State-of-the-Art review, we describe the unique biology of TRIM21, detail recently reported TRIMTACs, and suggest future opportunities for TRIMTACs to impact targeted protein degradation.

FEBS Journal
Case Western Reserve University (US)
National Institute of General Medical Sciences
Openalex Percentile: Top 8%
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.